Volume 32, Number 1—January 2026
Research
Enhanced Isolation and Detection of COVID-19 in Hospitalized Patients Undergoing Antiviral Therapy
Ranawaka A.P.M. Perera
, Andrew Marques, Jevon Graham-Wooten, Li Hui Tan, Noam Cohen, Kyle Rodino, Ronald G. Collman, Frederic D. Bushman, and Susan R. Weiss
, Andrew Marques, Jevon Graham-Wooten, Li Hui Tan, Noam Cohen, Kyle Rodino, Ronald G. Collman, Frederic D. Bushman, and Susan R. Weiss
Table 3
Three clinical specimens confirmed positive by real time reverse transcriptase PCR for the SARS-CoV-2 BA.5 Omicron variant from study on the enhanced isolation and detection of COVID-19 in hospitalized patients undergoing antiviral therapy
| Nasal swab ID | ALI | Vero E6 | Vero E6 T2 | Vero E6 A2T2 | p value |
|---|---|---|---|---|---|
| 1 | 7.3 ±0.1 | 6.3 ±0.2 | 6.1 ±0.3 | 5.1 ±0.2 | <0.001 |
| 17 | 7.5 ±0.1 | 6.2 ±0.3 | 5.2 ±0.3 | 5.5 ±0.3 | <0.01 |
| 20 | 7.0 ±0.3 | 6.6 ±0.3 | 5.5 ±0.2 | 5.5 ±0.2 | <0.01 |
*Values are mean ±SD. ID, identification.
Page created: December 30, 2025
Page updated: January 29, 2026
Page reviewed: January 29, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.